STOCK TITAN

Pediatrix Medical Group, Inc. - MD STOCK NEWS

Welcome to our dedicated page for Pediatrix Medical Group news (Ticker: MD), a resource for investors and traders seeking the latest updates and insights on Pediatrix Medical Group stock.

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent physician-led health solutions partner based in the United States. Founded in 1979, the company has grown into a national network of nearly 3,200 physicians operating in all 50 states and Puerto Rico. Pediatrix provides comprehensive physician services to hospitals, intensive care units, and other medical units, focusing on high-quality patient care and optimizing performance.

Pediatrix Medical Group offers specialized services in maternal care for expectant mothers, intensive care for premature babies, cardiology for infants with heart defects, and anesthesia during surgeries. The company primarily generates revenue through its neonatology and other pediatric subspecialties. Its physician practices and business professionals are dedicated to overcoming healthcare's quality, financial, and administrative complexities, continuously improving patient outcomes with evidence-based tools and clinical research.

Recent achievements include the formation of the Miller Children’s & Women’s Neonatal Network in partnership with MemorialCare Miller Children’s & Women’s Hospital Long Beach. This collaboration aims to enhance neonatal care through coordinated provider services, shared governance, and comprehensive support for high-risk maternal and neonatal care within the community. With services such as a level IV NICU, extremely low birth weight programs, and transport programs, the partnership underscores Pediatrix's commitment to expanding regional healthcare access.

Pediatrix Medical Group emphasizes continuous quality initiatives and safety improvements across its services. The company's clinical research and education efforts are pivotal in maintaining its reputation for delivering cost-effective and high-quality care. The physician-led structure supports an environment of compassionate and coordinated care, ensuring that the needs of women, babies, and children are met effectively.

To learn more about Pediatrix Medical Group, visit www.pediatrix.com or follow them on Facebook, Instagram, LinkedIn, and Twitter.

Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) reported third quarter 2024 results with net revenue of $511.2 million, up from $506.6 million in the prior year. The company achieved net income of $19.4 million, or $0.23 per share, compared to $21.4 million ($0.26 per share) in Q3 2023. Same-unit revenue grew 5.2%, driven by a 3.4% increase in reimbursement-related factors and 1.8% growth in patient volume. Adjusted EBITDA reached $60.2 million, up from $50.4 million year-over-year. The company maintains its 2024 Adjusted EBITDA guidance of $205-215 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.46%
Tags
-
Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) has announced its upcoming investor conference call and webcast, scheduled for Friday, November 1, 2024, at 9:00 a.m. ET. The event will focus on discussing the company's operational results for the quarter ending September 30, 2024.

A comprehensive press release detailing the results will be issued on the morning of November 1, 2024, prior to the opening of the securities markets. Investors and interested parties can access the conference call and webcast through the company's official website at www.pediatrix.com/investors.

This announcement provides an opportunity for stakeholders to gain insights into Pediatrix Medical Group's financial performance and operational achievements for the third quarter of 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
conferences
-
Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) reported a loss of $1.84 per share for Q2 2024, with Adjusted EPS of $0.34. Key results include:

- Net revenue: $504 million
- Net loss: $153 million
- Adjusted EBITDA: $58 million

The company saw 2.8% same-unit revenue growth, improved payor mix, and stable patient volumes. Pediatrix is implementing portfolio management plans, exiting most office-based practices except maternal-fetal medicine. The company expects these changes to have a $30 million favorable impact on Adjusted EBITDA. Pediatrix maintains its 2024 Adjusted EBITDA outlook of $200-$220 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.72%
Tags
Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) has announced its upcoming 2024 Second Quarter Conference Call and Webcast, scheduled for Tuesday, August 6, 2024, at 9:00 a.m. ET. The event will focus on discussing the company's operational results for the quarter ending June 30, 2024.

Investors and interested parties can access the webcast through Pediatrix's official website at www.pediatrix.com/investors. A detailed press release containing the quarterly results will be issued on the morning of August 6, 2024, before the securities markets open, providing stakeholders with comprehensive information prior to the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
conferences
-
Rhea-AI Summary

Pediatrix Medical Group (NYSE: MD) announced its participation in two upcoming healthcare investor conferences. The company will present at the Leerink Partners Healthcare Crossroads Conference in Austin, TX, on May 30, 2024, at 9:20 am CT, followed by the Jefferies Global Healthcare Conference in New York, NY, on June 6, 2024, at 7:30 am ET. Both events are anticipated to provide insights into Pediatrix's business strategies and growth prospects. Investors can access audio webcasts of these presentations on Pediatrix's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.45%
Tags
conferences
-
Rhea-AI Summary

Pediatrix Medical Group, Inc. reported earnings of $0.05 per share for the first quarter of 2024, with Adjusted EPS of $0.20. Net revenue was $495 million, net income was $4 million, and Adjusted EBITDA was $37 million. The company focused on operating efficiency and margin stabilization. Same-unit revenue increased by 2.3%, driven by patient volume growth. Expenses rose for clinical compensation and internal staffing. Adjusted EBITDA decreased to $37.2 million. Cash and cash equivalents were $8.0 million, with total debt of $705 million. The company expects 2024 Adjusted EBITDA to be $200-220 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
Rhea-AI Summary
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024, at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2024. A detailed press release will be issued the morning of May 7, 2024, before the securities markets open.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. (NYSE: MD) reported a loss from continuing operations of $1.50 per share for Q4 2023, with Adjusted EPS at $0.32. Net revenue was $496 million, while Adjusted EBITDA stood at $51 million. The company's operating plans for 2024 focus on reliable cash flow for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.93%
Tags
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. to host top meetings in neonatal-perinatal medicine to address the high preterm birth rate in the U.S. The company's commitment to enhancing clinical expertise and improving outcomes highlighted through continuing education opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
conferences
Rhea-AI Summary
Pediatrix Medical Group, Inc. (MD) will host an investor conference call and webcast to discuss Q4 2023 results. The detailed press release will be issued on February 20, 2024, before the securities markets open. The webcast will be accessible on Pediatrix's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.31%
Tags
none

FAQ

What is the current stock price of Pediatrix Medical Group (MD)?

The current stock price of Pediatrix Medical Group (MD) is $14.09 as of December 20, 2024.

What is the market cap of Pediatrix Medical Group (MD)?

The market cap of Pediatrix Medical Group (MD) is approximately 1.2B.

What services does Pediatrix Medical Group provide?

Pediatrix Medical Group provides physician services to hospitals, intensive care units, and other medical units, including maternal care, intensive care for premature babies, cardiology, and anesthesia.

Where does Pediatrix Medical Group operate?

Pediatrix Medical Group operates in all 50 states and Puerto Rico, providing services through a network of nearly 3,200 physicians.

What is the focus of Pediatrix Medical Group's services?

The focus is on high-quality patient care, optimizing performance, and overcoming healthcare's quality, financial, and administrative complexities. They emphasize neonatology and pediatric subspecialties.

What recent partnerships has Pediatrix Medical Group formed?

Pediatrix recently partnered with MemorialCare Miller Children’s & Women’s Hospital Long Beach to create the Miller Children’s & Women’s Neonatal Network, enhancing neonatal care in the region.

How does Pediatrix Medical Group improve patient outcomes?

Pediatrix uses evidence-based tools, continuous quality initiatives, and clinical research to enhance patient outcomes and deliver high-quality, cost-effective care.

What is the Miller Children’s & Women’s Neonatal Network?

It is a collaborative network between Pediatrix and MemorialCare Miller Children’s & Women’s Hospital Long Beach, designed to improve neonatal care through coordinated services and shared governance.

How can I learn more about Pediatrix Medical Group?

You can visit their website at www.pediatrix.com or follow them on social media platforms like Facebook, Instagram, LinkedIn, and Twitter.

What is the significance of Pediatrix’s physician-led structure?

The physician-led structure ensures that care is compassionate, coordinated, and clinically excellent, meeting the needs of women, babies, and children effectively.

What is the primary revenue source for Pediatrix Medical Group?

The majority of Pediatrix's revenue comes from neonatology and other pediatric subspecialties.

Does Pediatrix Medical Group invest in research and education?

Yes, Pediatrix invests significantly in research, education, quality improvement, and safety initiatives to maintain high standards of care.

Pediatrix Medical Group, Inc.

NYSE:MD

MD Rankings

MD Stock Data

1.22B
84.43M
1.69%
106.89%
4.39%
Medical Care Facilities
Services-hospitals
Link
United States of America
SUNRISE